Press Releases
27.09.2022
Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand
Corporate
Show Article
26.09.2022
BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company
Corporate
Show Article
29.08.2022
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
Finance
Show Article
20.06.2022
BRAIN Biotech publishes first ESG and Sustainability Report
Corporate
Show Article
30.05.2022
BRAIN Biotech AG: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting
Finance
Show Article
30.05.2022
Prof. Dr Bernhard Hauer leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Corporate
Show Article
04.04.2022
Successful Genome Editing in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)
Technology
Show Article
09.03.2022
Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG
Corporate
Finance
Show Article
23.02.2022
BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting
Finance
Show Article